Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea · Delayed Price · Currency is KRW 1,114.00
+67.00 (6.40%)
Nov 13, 2025, 4:10 PM KST
Enzychem Lifesciences Market Cap
Enzychem Lifesciences has a market cap or net worth of 86.71 billion as of November 13, 2025. Its market cap has decreased by -28.07% in one year.
Market Cap
86.71B
Enterprise Value
-20.24B
Revenue
72.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,114.00
Market Cap Chart
Since April 5, 2017, Enzychem Lifesciences's market cap has decreased from 217.47B to 86.71B, a decrease of -60.13%. That is a compound annual growth rate of -10.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 81.28B | -28.56% |
| Dec 30, 2024 | 113.77B | -26.43% |
| Dec 28, 2023 | 154.65B | 10.86% |
| Dec 29, 2022 | 139.50B | -69.50% |
| Dec 30, 2021 | 457.39B | -47.38% |
| Dec 30, 2020 | 869.25B | 57.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.24T |
| ALTEOGEN | 27.92T |
| SK Biopharmaceuticals | 9.36T |
| Yuhan | 8.57T |
| Peptron | 6.48T |
| HLB Co., Ltd. | 6.42T |
| Hanmi Pharm. | 5.62T |